Siblings Books/Book Section [1/1] Conference Papers/Meeting Abstract [116/180] Patents [0/4] Collection Statistics Item counts issued in 3 years:34(10.21%) Items With Fulltext:330(99.10%) Download counts of the item Download times greater than 0:330(100.00%) Download times greater than 100:317(96.06%) Total Bitstream Download Counts:143536(77.73%) Last Update: 2025-02-26 07:11 Top Upload Loading... Top Download Loading... Recent Submissions Pan-Asian adapted ESMO clinical pra... Perspectives of the medical oncolog... Cooperative participation of CagA a... Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati... Survival of advanced/recurrent gast... Topiramate suppresses peri-infarct ... A phase 1 study of biweekly nab-pac... Plain language summary of the FOENI... Outcomes of post-immunotherapy dura...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 76-100 of 333. (14 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2021-06-07	In vivo assessment of hypoxia levels in pancreatic tumors using a dual-modality ultrasound/photoacoustic imaging system	Micromachines. 2021 Jun 7;12(6):Article number 668.
2021-05-31	A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells	Frontiers in Oncology. 2021 May 31;11:Article number 638311.
2021-05	High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial	Radiotherapy and Oncology. 2021 May;158:146-154.
2021-04-28	Inhibition of Beta-catenin activity abolishes LKB1 loss-driven pancreatic cystadenoma in mice	International Journal of Molecular Sciences. 2021 Apr 28;22(9):Article number 4649.
2021-04-12	An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan	Scientific Reports. 2021 Apr 12;11:Article number 7881.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-03	A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma	Oncologist. 2021 Mar;26(3):e367-e373.
2021-01-13	Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials	Biomolecules. 2021 Jan 13;11(1):Article number 97.
2021-01	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2021 Jan;112(1):243-253.
2021-01	Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1	Pancreatology. 2021 Jan 10;21(1):192-199.
2020-12-29	Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan	PLoS ONE. 2020 Dec 29;15(12):Article number e0244487.
2020-11-13	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]	Scientific Reports. 2020 Nov 13;10:Article number 20199.
2020-10	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Liver International. 2020 Oct;40(10):2535-2543.
2020-07-01	A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue	Haematologica. 2020 Jul 1;105(7):e349-e354.
2020-07	JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions	Annals of Oncology. 2020 Jul;31(7):861-872.
2020-05-26	Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan	Journal of Biomedical Science. 2020 May 26;27:Article number 69.
2020-05-04	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort	Scientific Reports. 2020 May 4;10:Article number 7420.
2020-05	A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data	Gastric Cancer. 2020 May;23(3):510-519.
2020-05	Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in patients with pretreated biliary tract cancer	Journal for ImmunoTherapy of Cancer. 2020 May;8(1):Article number e00056.
2020-04	Management of early stage gastro-oesophageal cancers: Expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty	Expert Review of Anticancer Therapy. 2020 Apr;20(4):305-324.
2020-04	Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours	British Journal of Cancer. 2020 Apr;122(9):1324-1332.
2020-03	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO	Annals of Oncology. 2020 Mar;31(3):334-351.
2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study	Cancer Science. 2020 Feb;111(2):513-527.
2020-01	Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer	Gastric Cancer. 2020 Jan;23(1):143-153.

Showing items 76-100 of 333. (14 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page